HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS)
Clinical trials for HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS) explained in plain language.
Never miss a new study
Get alerted when new HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS) trials appear
Sign up with your email to follow new studies for HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at Hard-to-Treat blood cancers
Disease control Not yet recruitingThis early-phase study tests a new treatment called CD64 CAR T cells for people with acute myeloid leukemia (AML) or high-risk myelodysplastic syndromes (MDS) that have come back or not responded to standard therapy. The treatment involves taking a patient's own immune cells, mod…
Matched conditions: HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS)
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Scientists launch major biobank to unlock secrets of blood cancers
Knowledge-focused Not yet recruitingThis study will collect extra blood and bone marrow samples from 1000 adults with acute myeloid leukemia, acute lymphoblastic leukemia, or high-risk myelodysplastic syndrome. The samples will be used by researchers to better understand these diseases and find new ways to diagnose…
Matched conditions: HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS)
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC